| 0 (0%) | 11-11 17:49 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 220.57 | 1-year : | 257.62 |
| Resists | First : | 188.84 | Second : | 220.57 |
| Pivot price | 186.44 |
|||
| Supports | First : | 185.12 | Second : | 182.83 |
| MAs | MA(5) : | 186.36 |
MA(20) : | 186.39 |
| MA(100) : | 182.32 |
MA(250) : | 176.34 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 69.9 |
D(3) : | 51.6 |
| RSI | RSI(14): 60.7 |
|||
| 52-week | High : | 188.84 | Low : | 150.42 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VTV ] has closed below upper band by 11.0%. Bollinger Bands are 0.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 188.99 - 189.71 | 189.71 - 190.44 |
| Low: | 185.13 - 186.02 | 186.02 - 186.91 |
| Close: | 187.1 - 188.45 | 188.45 - 189.8 |
Tue, 11 Nov 2025
All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy - Yahoo Finance
Fri, 07 Nov 2025
vTv Therapeutics (NASDAQ:VTVT) Releases Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat
Fri, 07 Nov 2025
vTv Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview - TradingView
Fri, 07 Nov 2025
VTv Therapeutics: Q3 Earnings Snapshot - theheraldreview.com
Fri, 07 Nov 2025
VTv Therapeutics: Q3 Earnings Snapshot - ctinsider.com
Thu, 06 Nov 2025
How vTv Therapeutics Inc. stock performs in rising dollar environment - Earnings Summary Report & Weekly High Potential Alerts - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|